Cargando…
Neoadjuvant Chemotherapy Compared with Surgery for Oesophageal Carcinoma: A Retrospective Study and Missing Evidence
Background: Negative evidence for the use of neoadjuvant chemotherapy (NAC) to treat oesophageal squamous cell carcinoma (ESCC) has been reported in Western countries in the past century. However, in China, most ESCC patients underwent paclitaxel and platinum-based NAC without evidence from local RC...
Autores principales: | Zheng, Yan, Li, Keting, Liu, Xianben, Sun, Haibo, Wang, Zongfei, Liang, Guanghui, Zhang, Xinshuo, Ji, Jiachao, Xing, Wenqun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9969578/ https://www.ncbi.nlm.nih.gov/pubmed/36860915 http://dx.doi.org/10.7150/jca.81588 |
Ejemplares similares
-
The safety of neoadjuvant chemotherapy combined with non-tube nofasting fast-track surgery for esophageal carcinoma
por: Zheng, Yan, et al.
Publicado: (2022) -
The Role of Adjuvant Chemotherapy in the Treatment of Esophageal Squamous Cell Carcinoma after Neoadjuvant Chemotherapy
por: Li, Keting, et al.
Publicado: (2023) -
Relationship between postoperative complications of esophageal cancer surgery and season: a retrospective study
por: Liu, Xianben, et al.
Publicado: (2022) -
Multicentre Comparison of the Toxicity and Effectiveness of Lobaplatin-Based Versus Cisplatin-Based Adjuvant Chemotherapy in Oesophageal Carcinoma
por: Zheng, Yan, et al.
Publicado: (2021) -
Neoadjuvant chemotherapy followed by minimally invasive esophagectomy versus primary surgery for management of esophageal carcinoma: a retrospective study
por: Zheng, Yan, et al.
Publicado: (2019)